Algorithms for Processing Coronavirus Genomes for the Goals and Objectives of Modern Immunoinformatics, Vaccinomics, and Virology

The novel coronavirus pandemic has stimulated the scientific activity of virology and interdisciplinary sciences: medical cybernetics and bioinformatics. The article is focused on the study of algorithms for processing bioinformatic data of genomic origin predominantly for the purposes of predominan...

Full description

Saved in:
Bibliographic Details
Main Authors: M. V. Sprindzuk, A. S. Vladyko, L. P. Titov, Lu Zhuozhuang, V. I. Bernik
Format: Article
Language:Russian
Published: Ministry of Education of the Republic of Belarus, Establishment The Main Information and Analytical Center 2022-06-01
Series:Цифровая трансформация
Subjects:
Online Access:https://dt.bsuir.by/jour/article/view/663
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The novel coronavirus pandemic has stimulated the scientific activity of virology and interdisciplinary sciences: medical cybernetics and bioinformatics. The article is focused on the study of algorithms for processing bioinformatic data of genomic origin predominantly for the purposes of predominantly immunoinformatics and computational vaccinology. The schemes of algorithms developed by the authors for the analysis of bioinformatic data are presented. The algorithms for processing genomic information developed by the authors based on the analysis of the available literature and many years of experience in computational and laboratory experiments can be used not only for the design and analysis of epitope vaccine components, but also for the other tasks of computational virology and microbiology. In silico experiments on the analysis of bioinformatic data are relatively low-cost and multi-informative, but they require highly qualified scientists with extensive experience, interdisciplinary training, and, accordingly, a wide range of knowledge and skills. However, for the complete analysis and implementation of, for example, the epitope vaccines, subsequent validation by the laboratory and in vivo experiments are required.
ISSN:2522-9613
2524-2822